HC Wainwright & Co. Reiterates Buy on Biohaven, Maintains $59 Price Target

Benzinga · 11/26 10:14
HC Wainwright & Co. analyst Douglas Tsao reiterates Biohaven (NYSE:BHVN) with a Buy and maintains $59 price target.